Técnicas Reunidas, S.A.

BME:TRE Lagerbericht

Marktkapitalisierung: €856.2m

Técnicas Reunidas Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Técnicas Reunidas wird ein jährliches Gewinn- und Umsatzwachstum von 14.7% bzw. 4.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 16.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.3% betragen.

Wichtige Informationen

14.7%

Wachstumsrate der Gewinne

16.5%

EPS-Wachstumsrate

Energy Services Gewinnwachstum11.5%
Wachstumsrate der Einnahmen4.9%
Zukünftige Eigenkapitalrendite15.3%
Analystenabdeckung

Good

Zuletzt aktualisiert19 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Update: Here's Why Analysts Just Lifted Their Técnicas Reunidas, S.A. (BME:TRE) Price Target To €16.42

Aug 03
Earnings Update: Here's Why Analysts Just Lifted Their Técnicas Reunidas, S.A. (BME:TRE) Price Target To €16.42

Recent updates

Many Still Looking Away From Técnicas Reunidas, S.A. (BME:TRE)

Sep 19
Many Still Looking Away From Técnicas Reunidas, S.A. (BME:TRE)

Earnings Update: Here's Why Analysts Just Lifted Their Técnicas Reunidas, S.A. (BME:TRE) Price Target To €16.42

Aug 03
Earnings Update: Here's Why Analysts Just Lifted Their Técnicas Reunidas, S.A. (BME:TRE) Price Target To €16.42

Does Técnicas Reunidas (BME:TRE) Have A Healthy Balance Sheet?

Jun 15
Does Técnicas Reunidas (BME:TRE) Have A Healthy Balance Sheet?

Técnicas Reunidas, S.A.'s (BME:TRE) Shares Leap 39% Yet They're Still Not Telling The Full Story

May 24
Técnicas Reunidas, S.A.'s (BME:TRE) Shares Leap 39% Yet They're Still Not Telling The Full Story

Not Many Are Piling Into Técnicas Reunidas, S.A. (BME:TRE) Just Yet

Apr 04
Not Many Are Piling Into Técnicas Reunidas, S.A. (BME:TRE) Just Yet

Here's Why Técnicas Reunidas (BME:TRE) Has A Meaningful Debt Burden

Aug 11
Here's Why Técnicas Reunidas (BME:TRE) Has A Meaningful Debt Burden

Is Técnicas Reunidas, S.A. (BME:TRE) Trading At A 23% Discount?

Mar 08
Is Técnicas Reunidas, S.A. (BME:TRE) Trading At A 23% Discount?

Is Técnicas Reunidas (BME:TRE) Using Debt In A Risky Way?

Oct 27
Is Técnicas Reunidas (BME:TRE) Using Debt In A Risky Way?

Health Check: How Prudently Does Técnicas Reunidas (BME:TRE) Use Debt?

Nov 03
Health Check: How Prudently Does Técnicas Reunidas (BME:TRE) Use Debt?

Does Técnicas Reunidas (BME:TRE) Have A Healthy Balance Sheet?

Jul 09
Does Técnicas Reunidas (BME:TRE) Have A Healthy Balance Sheet?

Based On Its ROE, Is Técnicas Reunidas, S.A. (BME:TRE) A High Quality Stock?

Mar 10
Based On Its ROE, Is Técnicas Reunidas, S.A. (BME:TRE) A High Quality Stock?

Técnicas Reunidas (BME:TRE) Share Prices Have Dropped 51% In The Last Three Years

Feb 12
Técnicas Reunidas (BME:TRE) Share Prices Have Dropped 51% In The Last Three Years

Is Técnicas Reunidas, S.A. (BME:TRE) Worth €11.8 Based On Its Intrinsic Value?

Jan 14
Is Técnicas Reunidas, S.A. (BME:TRE) Worth €11.8 Based On Its Intrinsic Value?

Could The Técnicas Reunidas, S.A. (BME:TRE) Ownership Structure Tell Us Something Useful?

Dec 14
Could The Técnicas Reunidas, S.A. (BME:TRE) Ownership Structure Tell Us Something Useful?

Gewinn- und Umsatzwachstumsprognosen

BME:TRE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20265,003152109N/A5
12/31/20254,797119122N/A5
12/31/20244,50910772N/A6
9/30/20244,10884N/AN/AN/A
6/30/20244,0586294102N/A
3/31/20244,01962N/AN/AN/A
12/31/20234,135616983N/A
9/30/20234,66854N/AN/AN/A
6/30/20234,75172-15-4N/A
3/31/20234,580-19N/AN/AN/A
12/31/20224,233-378184N/A
9/30/20223,514-83N/AN/AN/A
6/30/20223,038-97-136-132N/A
3/31/20222,818-130N/AN/AN/A
12/31/20212,806-190-270-267N/A
9/30/20212,816-152N/AN/AN/A
6/30/20212,834-1631110N/A
3/31/20213,102-56N/AN/AN/A
12/31/20203,52111-121-117N/A
9/30/20204,080-26N/AN/AN/A
6/30/20204,591-11-88-72N/A
3/31/20204,965-6N/AN/AN/A
12/31/20194,699-9137151N/A
9/30/20194,56932N/AN/AN/A
6/30/20194,3542094100N/A
3/31/20194,15016N/AN/AN/A
12/31/20184,39612102108N/A
9/30/20184,4419N/AN/AN/A
6/30/20184,699-12N/A71N/A
3/31/20184,8413N/AN/AN/A
12/31/20175,06840N/A-169N/A
9/30/20175,23794N/AN/AN/A
6/30/20175,117131N/A-194N/A
3/31/20175,129146N/AN/AN/A
12/31/20164,793140N/A59N/A
9/30/20164,62045N/AN/AN/A
6/30/20164,60851N/A195N/A
3/31/20164,33352N/AN/AN/A
12/31/20154,18859N/A-18N/A
9/30/20153,857151N/AN/AN/A
6/30/20153,554143N/A-139N/A
3/31/20153,327141N/AN/AN/A
12/31/20143,149136N/A138N/A
9/30/20143,039125N/AN/AN/A
6/30/20142,930128N/A152N/A
3/31/20142,884125N/AN/AN/A
12/31/20132,846128N/A85N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: TREDas prognostizierte Gewinnwachstum (14.7% pro Jahr) liegt über der Sparquote (1.8%).

Ertrag vs. Markt: TREDie Erträge des Unternehmens (14.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Spanish (8.5% pro Jahr).

Hohe Wachstumserträge: TREDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: TREDie Einnahmen des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Spanish (4.9% pro Jahr).

Hohe Wachstumseinnahmen: TREDie Einnahmen des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: TREDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.3%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y